“…It reduces the adipose tissue mass and increases the tissue sensitivity to insulin, thereby reducing hyperglycemia, normalizing carbohydrate and lipid metabolism and preventing inflammation and oxidative stress in the tissues [ 1 , 2 ]. MF is also used to treat non-alcoholic fatty liver disease [ 3 ], coronary artery disease [ 4 , 5 ], acute kidney injury and chronic kidney disease [ 6 ], in patients with T2DM, metabolic syndrome (MetS) and obesity, and in patients without apparent symptoms of metabolic disorders [ 7 ]. There are numerous clinical and experimental studies indicating the effectiveness of MF as an anticancer drug, used to prevent the growth and metastasis in breast cancer [ 8 , 9 ], endometrial cancer [ 10 , 11 , 12 ], colorectal cancer [ 9 , 13 ], prostate cancer [ 14 ] and in a number of the other tumors [ 15 , 16 ].…”